CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction
CD 8 T 细胞介导的血脑紧密连接破坏
基本信息
- 批准号:8306282
- 负责人:
- 金额:$ 33.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAddressAdoptive TransferAffectAnimalsAreaAstrocytesBiological AssayBiological ModelsBiological PreservationBloodBlood - brain barrier anatomyBlood VesselsBone MarrowBrainBrothersC57BL/6 MouseCD4 Positive T LymphocytesCD8B1 geneCandidate Disease GeneCellsCellular ImmunologyCerebral MalariaCerebrumCessation of lifeChimera organismChromosomesCollaborationsDataDatabasesDiseaseEndothelial CellsGenerationsGenesGeneticGenetic VariationGoalsHealthHematopoieticHourHumanImageImmuneImmune systemIn VitroInflammationInflammation MediatorsInflammatoryInformaticsInterferonsInterleukin-1InterventionKnowledgeLaboratoriesLeadLinkLocationMapsMediatingMicrosatellite RepeatsModelingModificationMolecularMolecular BiologyMonitorMorbidity - disease rateMotorMultiple SclerosisMusNeuraxisNeurologicOther GeneticsPartner in relationshipPathologicPennsylvaniaPeptidesPermeabilityPhenotypePlayPredispositionProcessProtein BiochemistryProteinsQuantitative Trait LociRelative (related person)ResearchResearch PersonnelResistanceResourcesRetroviridaeRoleShockSisterSolidSourceStrokeSymptomsSyndromeSystemT cell responseT-LymphocyteTMEVTNF geneTechniquesTestingTherapeutic InterventionTight JunctionsTransgenic MiceUniversitiesVascular PermeabilitiesViral Hemorrhagic FeversVirus DiseasesWorkbasecell typechemotherapycongeniccytotoxicdesignexpectationexperiencegenetic analysisgenome wide association studyhuman diseasein vivoinnovationmortalitymouse genomemouse modelnervous system disordernovelnovel therapeuticsperforinreconstitutionresponseretroviral transductiontherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Disruption of the Blood Brain Barrier (BBB) is common pathologic feature of numerous serious neurological diseases. Despite the enormous burden of morbidity and mortality due to these neurological diseases associated with CNS vascular permeability, the underlying molecular mechanisms of how inflammatory cells promote BBB disruption remain poorly understood. We have developed a novel murine model of CNS vascular permeability that provides a tractable approach to defining specific inflammatory mediators that disrupt the BBB in vivo using Theiler's virus infection. This murine model of BBB disruption is initiated by peptide-specific stimulation of CNS infiltrating CD8 T cells and is not mediated by TNF-a, IFN-?, LT¿R and IL- 1. However, perforin is critical for both CNS vascular permeability and preservation of BBB tight junctions. Notably, MHC-identical C57BL/6 and 129 Svlm mice differ dramatically in susceptibility to PIFS, despite having identical CD8+ T cell responses and CTL activity. The goal of this proposal is to test our underlying hypothesis that CD8 T cells utilize perforin to initiate the disruption of cerebral endothelial cell BBB tight junctions. Specific modifier genes on the C57BL/6 and 129 SvIm mouse background are also critical for this process to occur. We will determine using this model: 1.) the cellular source of perforin necessary for BBB disruption, 2.) the role of hematopoetic cells in promoting disruption of the BBB, and 3.) the chromosome location of genetic factors that govern BBB disruption. We will use conventional genetic analysis, protein biochemistry, imaging, cellular immunology assays, molecular biology and retrovirus expression to determine the inflammatory factors that mediate disruption of the BBB. Identification of powerful factors that contribute to fatal CNS vascular permeability would define targets for therapeutic modification of the BBB. Such diseases characterized by disruption of the BBB including stroke, viral hemorrhagic fevers, cerebral malaria, HIV dementia, multiple sclerosis (MS), and shock. Increased understanding of BBB permeability could also benefit chemotherapy. PUBLIC HEALTH RELEVANCE: Inflammation mediated blood brain barrier (BBB) disruption is a poorly understood, yet relatively common feature of numerous neurologic diseases. We have developed a novel murine model of CNS vascular permeability that can be utilized to define specific cellular interactions and inflammatory mediators that result in disruption of the BBB in vivo. Defining such factors is the first step towards novel therapeutic modification of BBB permeability.
Description of the Blood Brain Barrier (BBB) is Common Pathologic Feature of Nuurological Despitee The Enormous Burden of Mortality Due to TheSE NEUROLOLOSEASES SSSOCIATED WITH CNS VASCULAR PERMEABITY Lying Molecular Mechanisms of How I Have Development Remain Poor Understood. We Have Developed a novel Murine CNS血管VIDES的模型用于定义特定的炎症者使用其US感染破坏BBB的BBB的模型。 lt¿ R和IL -1。连接。在控制BBB的遗传因素中,HIV痴呆,多发性硬化症(MS)和冲击:炎症介导的血脑屏障(BBB)破坏是一个不足的海洋。导致BBB体内破坏的介体是定义此类因素的第一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aaron J Johnson其他文献
Aaron J Johnson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aaron J Johnson', 18)}}的其他基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 33.7万 - 项目类别:
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞
- 批准号:
10229223 - 财政年份:2021
- 资助金额:
$ 33.7万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
10609855 - 财政年份:2017
- 资助金额:
$ 33.7万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
9392836 - 财政年份:2017
- 资助金额:
$ 33.7万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
10199061 - 财政年份:2017
- 资助金额:
$ 33.7万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
10391533 - 财政年份:2017
- 资助金额:
$ 33.7万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
9293869 - 财政年份:2016
- 资助金额:
$ 33.7万 - 项目类别:
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction
CD 8 T 细胞介导的血脑紧密连接破坏
- 批准号:
8509031 - 财政年份:2009
- 资助金额:
$ 33.7万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Meninges-to-astrocyte communication in cognitive function
认知功能中的脑膜与星形胶质细胞的通讯
- 批准号:
8279364 - 财政年份:2010
- 资助金额:
$ 33.7万 - 项目类别:
Meninges-to-astrocyte communication in cognitive function
认知功能中的脑膜与星形胶质细胞的通讯
- 批准号:
8663780 - 财政年份:2010
- 资助金额:
$ 33.7万 - 项目类别:
Meninges-to-astrocyte communication in cognitive function
认知功能中的脑膜与星形胶质细胞的通讯
- 批准号:
8063466 - 财政年份:2010
- 资助金额:
$ 33.7万 - 项目类别:
Meninges-to-astrocyte communication in cognitive function
认知功能中的脑膜与星形胶质细胞的通讯
- 批准号:
8461173 - 财政年份:2010
- 资助金额:
$ 33.7万 - 项目类别:
Meninges-to-astrocyte communication in cognitive function
认知功能中的脑膜与星形胶质细胞的通讯
- 批准号:
7898350 - 财政年份:2010
- 资助金额:
$ 33.7万 - 项目类别: